The Science of
Functional Mushrooms

A 16-week double-blind, placebo-controlled trial in 30 Japanese men and women (ages 50–80) with mild cognitive impairment found that the group receiving Lion's Mane mushroom tablets (250 mg, 3× daily) showed significantly improved scores on cognitive function scales compared to placebo. Cognitive improvements increased with duration of intake, but scores decreased after supplementation ceased — suggesting ongoing use is beneficial.

This 2025 study examined the acute cognitive effects of a standardised Lion's Mane extract in healthy young adults. Participants receiving Lion's Mane showed improvements in processing speed and attention tasks compared to placebo within hours of supplementation, suggesting bioactive compounds may have both acute and long-term cognitive benefits.

This pilot study investigated both acute (single-dose) and chronic (28-day) effects of Lion's Mane supplementation in young adults. Chronic supplementation resulted in a significant reduction in subjective stress and improvements in cognitive task performance, supporting Lion's Mane's dual potential as both an acute cognitive enhancer and long-term adaptogen.

This randomized controlled trial evaluated the immunomodulatory effects of Reishi-derived beta-glucans in healthy adult volunteers. Participants receiving the beta-glucan supplement showed enhanced natural killer (NK) cell activity and improved immune markers compared to placebo, supporting Reishi's traditional reputation as an immune-modulating adaptogen.

Published in Nature's Scientific Reports, this study identified a novel mechanism by which Reishi promotes sleep: through modulation of the gut microbiota and subsequent increases in serotonin signaling. The research demonstrated that Reishi's triterpene-rich extract significantly increased total sleep time and non-REM sleep, with the effect dependent on an intact gut microbiome — highlighting the gut-brain axis connection.

This clinical study investigated Reishi's immune-restorative properties in immunocompromised patients post-chemotherapy. Participants supplementing with Reishi broken spore powder showed improved immunoglobulin levels and quality-of-life scores, with no significant adverse effects reported — supporting both the efficacy and safety profile of Reishi supplementation.

Twenty-eight participants were randomized to receive Cordyceps militaris or placebo for 3 weeks. The Cordyceps group demonstrated significant improvements in VO₂max (maximal oxygen consumption) after both 1 and 3 weeks of supplementation compared to placebo, as well as increased time to exhaustion during high-intensity exercise — supporting Cordyceps' role in enhancing aerobic capacity and exercise performance.

This study elucidated the mechanism behind Cordyceps' performance-enhancing effects. Cordycepin and adenosine — key bioactive compounds — were shown to directly promote cellular ATP (adenosine triphosphate) production and improve mitochondrial efficiency. The findings provide molecular evidence for Cordyceps' traditional use as an energy and endurance tonic.

This sports nutrition study examined chronic supplementation of a Cordyceps-containing mushroom blend on athletic performance markers. Participants showed improvements in oxygen kinetics during exercise, peak power output, and time to exhaustion, adding to the growing evidence base for Cordyceps as a natural ergogenic aid.

This study characterized the melanin pigments unique to Chaga mushroom and demonstrated their dual functionality: potent antioxidant activity (scavenging multiple types of free radicals) and prebiotic effects that selectively promoted the growth of beneficial Bifidobacterium species. The findings suggest Chaga melanins contribute to both cellular protection and gut microbiome health simultaneously.

Researchers demonstrated that Chaga mushroom decoction exhibited significant anti-glycation activity (inhibiting the formation of advanced glycation end products, or AGEs) alongside strong antioxidant capacity. AGEs are implicated in aging and metabolic health challenges, positioning Chaga as a potential natural agent for cellular longevity support.

This foundational study identified and characterized the specific phenolic compounds responsible for Chaga's extraordinary antioxidant capacity. Multiple phenolic acids, including protocatechuic acid, caffeic acid, and syringic acid, were isolated and shown to exhibit potent free radical-scavenging activity — establishing the chemical basis for Chaga's reputation as an antioxidant powerhouse.

This NIH-funded Phase 1 clinical trial evaluated Turkey Tail mushroom supplementation in women with breast cancer following standard treatment. The study found that Turkey Tail was well-tolerated at doses up to 9 g/day and demonstrated dose-dependent immunological improvements, including enhanced NK cell activity and increased lymphocyte counts — markers of immune system recovery after conventional treatment.

This comprehensive review examined the clinical evidence for PSK (Polysaccharide-K), a compound extracted from Turkey Tail mushroom that has been approved as an adjunctive treatment in Japan since the 1970s. The review summarized multiple randomized controlled trials demonstrating PSK's ability to improve immune markers and quality of life when used alongside conventional treatment protocols.

This Cochrane systematic review — considered the gold standard in evidence-based medicine — evaluated the totality of clinical evidence for Turkey Tail mushroom in colorectal cancer supportive care. The review catalogued the existing randomized controlled trials on PSK and PSP polysaccharides, highlighting their established role in the Japanese medical system and the need for further high-quality Western trials.